156 related articles for article (PubMed ID: 30282627)
1. Need for evidence-based early intervention programmes: a public health perspective.
Guloksuz S; van Os J
Evid Based Ment Health; 2018 Nov; 21(4):128-130. PubMed ID: 30282627
[TBL] [Abstract][Full Text] [Related]
2. [Detection and early treatment of subjects at high risk of clinical psychosis: Definitions and recommendations].
Michel C; Toffel E; Schmidt SJ; Eliez S; Armando M; Solida-Tozzi A; Schultze-Lutter F; Debbané M
Encephale; 2017 May; 43(3):292-297. PubMed ID: 28347521
[TBL] [Abstract][Full Text] [Related]
3. A critique of the "ultra-high risk" and "transition" paradigm.
van Os J; Guloksuz S
World Psychiatry; 2017 Jun; 16(2):200-206. PubMed ID: 28498576
[TBL] [Abstract][Full Text] [Related]
4. Early psychotic experiences: Interventions, problems and perspectives.
Dimitrakopoulos S; Kollias C; Stefanis NC; Kontaxakis V
Psychiatriki; 2015; 26(1):45-54. PubMed ID: 25880383
[TBL] [Abstract][Full Text] [Related]
5. EPA guidance on the early detection of clinical high risk states of psychoses.
Schultze-Lutter F; Michel C; Schmidt SJ; Schimmelmann BG; Maric NP; Salokangas RK; Riecher-Rössler A; van der Gaag M; Nordentoft M; Raballo A; Meneghelli A; Marshall M; Morrison A; Ruhrmann S; Klosterkötter J
Eur Psychiatry; 2015 Mar; 30(3):405-16. PubMed ID: 25735810
[TBL] [Abstract][Full Text] [Related]
6. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
[TBL] [Abstract][Full Text] [Related]
7. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort.
Koutsouleris N; Worthington M; Dwyer DB; Kambeitz-Ilankovic L; Sanfelici R; Fusar-Poli P; Rosen M; Ruhrmann S; Anticevic A; Addington J; Perkins DO; Bearden CE; Cornblatt BA; Cadenhead KS; Mathalon DH; McGlashan T; Seidman L; Tsuang M; Walker EF; Woods SW; Falkai P; Lencer R; Bertolino A; Kambeitz J; Schultze-Lutter F; Meisenzahl E; Salokangas RKR; Hietala J; Brambilla P; Upthegrove R; Borgwardt S; Wood S; Gur RE; McGuire P; Cannon TD
Biol Psychiatry; 2021 Nov; 90(9):632-642. PubMed ID: 34482951
[TBL] [Abstract][Full Text] [Related]
8. Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention.
Fusar-Poli P; Salazar de Pablo G; Correll CU; Meyer-Lindenberg A; Millan MJ; Borgwardt S; Galderisi S; Bechdolf A; Pfennig A; Kessing LV; van Amelsvoort T; Nieman DH; Domschke K; Krebs MO; Koutsouleris N; McGuire P; Do KQ; Arango C
JAMA Psychiatry; 2020 Jul; 77(7):755-765. PubMed ID: 32159746
[TBL] [Abstract][Full Text] [Related]
9. Characterization of young people with first episode psychosis or at ultra-high risk: the Reggio Emilia At-Risk Mental States (ReARMS) program.
Pelizza L; Azzali S; Paterlini F; Garlassi S; Scazza I; Chiri LR; Poletti M; Pupo S; Raballo A
Riv Psichiatr; 2019; 54(6):254-263. PubMed ID: 31909752
[TBL] [Abstract][Full Text] [Related]
10. Comparison of high and low intensity contact between secondary and primary care to detect people at ultra-high risk for psychosis: study protocol for a theory-based, cluster randomized controlled trial.
Perez J; Russo DA; Stochl J; Byford S; Zimbron J; Graffy JP; Painter M; Croudace TJ; Jones PB
Trials; 2013 Jul; 14():222. PubMed ID: 23866815
[TBL] [Abstract][Full Text] [Related]
11. Adolescents at ultra-high risk of psychosis in Italian neuropsychiatry services: prevalence, psychopathology and transition rate.
Pelizza L; Azzali S; Garlassi S; Paterlini F; Scazza I; Chiri LR; Pupo S; Raballo A
Eur Child Adolesc Psychiatry; 2018 Jun; 27(6):725-737. PubMed ID: 29058115
[TBL] [Abstract][Full Text] [Related]
12. Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study.
Thompson A; Nelson B; Bechdolf A; Chanen AM; Domingues I; McDougall E; Yung AR
Early Interv Psychiatry; 2012 Aug; 6(3):247-55. PubMed ID: 22672502
[TBL] [Abstract][Full Text] [Related]
13. Checking the predictive accuracy of basic symptoms against ultra high-risk criteria and testing of a multivariable prediction model: Evidence from a prospective three-year observational study of persons at clinical high-risk for psychosis.
Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
Eur Psychiatry; 2017 Sep; 45():27-35. PubMed ID: 28728092
[TBL] [Abstract][Full Text] [Related]
14. Applying economic models to estimate local economic benefits of improved coverage of early intervention for psychosis.
Campion J; Taylor MJ; McDaid D; Park AL; Shiers D
Early Interv Psychiatry; 2019 Dec; 13(6):1424-1430. PubMed ID: 30740880
[TBL] [Abstract][Full Text] [Related]
15. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
[TBL] [Abstract][Full Text] [Related]
16. The Ultra-High-Risk for psychosis groups: Evidence to maintain the status quo.
McHugh MJ; McGorry PD; Yuen HP; Hickie IB; Thompson A; de Haan L; Mossaheb N; Smesny S; Lin A; Markulev C; Schloegelhofer M; Wood SJ; Nieman D; Hartmann JA; Nordentoft M; Schäfer M; Amminger GP; Yung A; Nelson B
Schizophr Res; 2018 May; 195():543-548. PubMed ID: 29055567
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic interventions in prodromal psychosis: safety issues.
Liu CC; Demjaha A
CNS Drugs; 2013 Mar; 27(3):197-205. PubMed ID: 23436256
[TBL] [Abstract][Full Text] [Related]
18. Basic symptoms in young people at ultra-high risk of psychosis: Association with clinical characteristics and outcomes.
Youn S; Phillips LJ; Amminger GP; Berger G; Chen EYH; de Haan L; Hartmann JA; Hickie IB; Lavoie S; Markulev C; McGorry PD; Mossaheb N; Nieman DH; Nordentoft M; Riecher-Rössler A; Schäfer MR; Schlögelhofer M; Smesny S; Thompson A; Verma S; Yuen HP; Yung AR; Nelson B
Schizophr Res; 2020 Feb; 216():255-261. PubMed ID: 31866077
[TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
[TBL] [Abstract][Full Text] [Related]
20. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
